Wednesday
Mar042009
There is hope coming for prescription consumers
Wednesday, March 4, 2009 at 9:01PM
by Christina Lovato, University of New Mexico-Talk Radio News Service
Today in a press conference held by Senators Byron Dorgan (D-ND), Olympia Snowe (R-ME), John McCain (R-AZ), and Debbie Stabenow (D-MI) an announcement was made about the introduction of a drug importation legislation that will reduce the cost of prescription drugs in the United States. The “Pharmaceutical Market Access and Drug Safety Act” the Senators stated will bring consumers immediate relief and will force the pharmaceutical industry to lower drug prices in the United States.
The bill, which is the same as last year’s proposal by President Obama, will allow U.S. drug wholesalers and licensed pharmacies to import FDA-approved medications from Australia, Canada, Europe, New Zealand and Japan. The costs in these countries, which are 35 to 55 percent lower than in the U.S. will allow Americans to benefit from these prices also. The legislation only applies to FDA-approved prescription drugs produced in FDA-approved plants from countries with the same safety standards.
At the conference Senator Dorgan pointed out a comparison between the drug Lipitor that is made in Ireland which gets distributed to both Canada and the United States. “I have in fact two bottles here, the only difference is in color, one is red and one is blue...The only difference is the U.S. consumer gets to pay more than twice as much for the identical pill put in the same bottle. That’s unfair we believe.”
Senator Stabenow stated “This is not like buying a pair of shoes or buying some other commodity when you cant get your medicine, it literally is life threatening so this is a very serious issue for people and we can make a dramatic difference by passing this legislation.”
Senator Dorgan said that he is confident that President Obama and his administration will support this bill because Obama introduced the exact piece of legislation last year. “He and his chief of staff co-sponsored this identical bill...You would expect a President that signed up as a member of senate for this identical bill to support it as he already has done in his budget message.” Dorgan concluded.
Today in a press conference held by Senators Byron Dorgan (D-ND), Olympia Snowe (R-ME), John McCain (R-AZ), and Debbie Stabenow (D-MI) an announcement was made about the introduction of a drug importation legislation that will reduce the cost of prescription drugs in the United States. The “Pharmaceutical Market Access and Drug Safety Act” the Senators stated will bring consumers immediate relief and will force the pharmaceutical industry to lower drug prices in the United States.
The bill, which is the same as last year’s proposal by President Obama, will allow U.S. drug wholesalers and licensed pharmacies to import FDA-approved medications from Australia, Canada, Europe, New Zealand and Japan. The costs in these countries, which are 35 to 55 percent lower than in the U.S. will allow Americans to benefit from these prices also. The legislation only applies to FDA-approved prescription drugs produced in FDA-approved plants from countries with the same safety standards.
At the conference Senator Dorgan pointed out a comparison between the drug Lipitor that is made in Ireland which gets distributed to both Canada and the United States. “I have in fact two bottles here, the only difference is in color, one is red and one is blue...The only difference is the U.S. consumer gets to pay more than twice as much for the identical pill put in the same bottle. That’s unfair we believe.”
Senator Stabenow stated “This is not like buying a pair of shoes or buying some other commodity when you cant get your medicine, it literally is life threatening so this is a very serious issue for people and we can make a dramatic difference by passing this legislation.”
Senator Dorgan said that he is confident that President Obama and his administration will support this bill because Obama introduced the exact piece of legislation last year. “He and his chief of staff co-sponsored this identical bill...You would expect a President that signed up as a member of senate for this identical bill to support it as he already has done in his budget message.” Dorgan concluded.
Baucus Accuses Kyl Of Stalling Markup Of Health Care Reform Bill
While the third day of the Senate Finance Committee's markup of the "America's Healthy Future Act" opened Thursday with an exchange of bipartisan jokes, it quickly turned serious as Chairman Max Baucus (D-Mont.) painted Senator Orrin Hatch (D-Utah) and other members of the conservative caucus as defenders of the status quo. Baucus also accused Sen. Jon Kyl (R-Ariz.) for stalling the markup process.
Senator Chuck Grassley (R- Iowa) strongly criticized Medicare drug benefits and doughnut-hole dual eligible Americans, saying that the Baucus bill, “would undermine the [Medicare] part D program. Added Grassley, "The [Congressional Budget Office] is like God around here,” a reference to CBO estimates that the nation would face increased deficits if the bill is passed.
Democratic committee members on Thursday said they would focus on gaining the backing of the centrists in their own party, particularly Sen. Blanche Lincoln (D-Ark.). In addition, Democrats were expected to attempt to win over the support of Sen. Olympia Snowe (R-Maine), a moderate Republican who is viewed as a potential swing vote.
With 564 amendments, the markup of the America's Healthy Future Act 2009 is expected to continue into next week.